Abstract:Critical Care Medicine www.ccmjournal.org 2651 Objective : To characterize predictors of insulin-like growth factor-1 and insulin-like growth factor–binding protein-3 in acute critical illness with the hypothesis that acute factors associated with critical illness will more strongly predict circulating insulin-like growth factor-1 and insulin-like growth factor–binding protein-3 than chronic clinical or genetic factors. Design: Observational study nested within a large prospective study using multivariable linear regression to model circulating insulin-like growth factor-1 and insulin-like growth factor–binding protein-3 with acute and chronic clinical variables, and genotype from five polymorphisms in insulin-like growth factor pathway genes. Setting: ICUs from two large academic medical centers. Patients: Five hundred forty-three Caucasian patients with risk factors for acute respiratory distress syndrome and available plasma from early in critical illness. Interventions: None. Measurements and Main Results: Total insulin-like growth factor-1 and insulin-like growth factor–binding protein-3 were measured in plasma using IMMULITE assays (Siemens, Malvern, PA). We examined age, gender, body mass index, cirrhosis, and diabetes, as well as Acute Physiology, Age, and Chronic Health Evaluation III score, acute hepatic dysfunction, pneumonia and aspiration, sepsis/septic shock, acute respiratory distress syndrome, and receipt of corticosteroids. Body mass index, cirrhosis, and acute respiratory distress syndrome were strongly associated with insulin-like growth factor-1 and insulin-like growth factor–binding protein-3 levels; Acute Physiology, Age, and Chronic Health Evaluation III was strongly associated with insulin-like growth factor-1 levels; and age was strongly associated with insulin-like growth factor–binding protein-3. Five polymorphisms (IGF1: rs1520220, rs35767, rs2946834; IGFBP1: rs4619; IGFBP3: rs2854746) were analyzed for associations with plasma levels. When genotypes were added to models, rs2854746 was significantly associated with plasma insulin-like growth factor–binding protein-3. Genotype explained an additional 2% of variability with an overall adjusted R-square of 0.18. Conclusions: Despite the acute derangements of critical illness, both acute and chronic health factors significantly influence circulating levels of insulin-like growth factor-1 and insulin-like growth factor–binding protein-3 early in critical illness. rs2854746 is also significantly associated with insulin-like growth factor–binding protein-3 levels in this ICU cohort. Overall, phenotypic and genotypic factors explained only a modest amount of variability in Copyright © 2015 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved. DOI: 10.1097/CCM.0000000000001314 *See also p. 2695. 1Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT. 2Environmental and Occupational Medicine and Epidemiology Program, Department of Environmental Health, Harvard School of Public Health, Boston, MA. 3Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Boston, MA. 4Pulmonary and Critical Care Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA. Supported, in part, by a grant R01HL60710 from the National Institutes of Health and a grant 10FTF3440007 from the American Heart Association. Dr. Ahasic received support for article research from the National Institutes of Health (NIH) and the American Heart Association. Her institution received grant support from the American Heart Association (she has a career development grant [10FTF3440007] funding this research, disclosed in the article), and she received support for travel from the American Heart Association (the career development grant allows up to $3000/ yr for travel to academic conferences relevant to the current research; no travel money has been received outside of this grant). Dr. Mantzoros has disclosed government work. Dr. Thompson consulted for GlaxoSmithKline (one-time acute respiratory distress syndrome [ARDS] advisory board meeting) and received support for article research form the NIH. He is currently receiving funding (1U01HL123009-1) from the National Institutes of Health/National Heart, Lung & Blood Institute (NHLBI). His institution received grant support from the NHLBI (conduct sepsis and ARDS clinical research). Dr. Christiani is currently receiving funding from the National Institutes of Health (NHLBI: R01HL060710 and T32HL116275; National Cancer Institute: P30CA006516 and R01CA092824; National Institute of Environmental Health Sciences: R01 ES009860 and T32 ES007069) and from the Centers for Disease Control (National Institute for Occupational Safety & Health: R01OH002421 and T42OH008416). His institution received grant support from the NIH (NHLBI). The remaining authors have disclosed that they do not have any potential conflicts of interest. For information regarding this article, E-mail: amy.ahasic@yale.edu Predictors of Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor–Binding Protein-3 in Critical Illness*

Clinical Significance of Changes of Serum GH and TF Levels in Critical Patients

[Nutritional Status in Acute Stage Ischemic Stroke and Its Relation to Disease Severity and Prognosis of Patients].

Attitudes Toward the American Nutrition Guidelines for the Critically Ill Patients of Chinese Intensive Care Physicians.

Predictors Of Circulating Insulin-Like Growth Factor-1 And Insulin-Like Growth Factor-Binding Protein-3 In Critical Illness

Serum Insulin-Like Growth Factor 1 Level and Nutritional Assessment in Nondialytic Patients with Chronic Renal Failure.

Nutritional Status of Patients with Chronic Critical Illness

Full versus Trophic Feeds in Critically Ill Adults with High and Low Nutritional Risk Scores: A Randomized Controlled Trial

Significance of Hormone and Cytokine in the Assess of Nutritional Status of Aged Patients with Pneumonia

Transthyretin and Nutritional Status in Critically Ill Adults on Parenteral Nutrition: A Prospective Cohort Study

A cross-sectional study on nutritional status of ICU patients in the mainland China

A Study of the Combinant Application of PN and GH in the Therapy of Critical Care Patients

Insulin-like Growth Factor-1 As a Nutritional Monitoring Factor in Patients with Chronic Intestinal Failure.

Lipid level and 28-days mortality among patients in urgency room

Postoperative changes of serum proteins and immune response in criticalpatients and the effects of recombinant human growth hormone

Clinical significance of changes in cytokine levels in patients with severe abdominal infection

Nutritional support treatment in critically ill patients with kidney disease: a prospective study

Association Between Serum C-Reactive Protein Concentration and Nutritional Status of Malignant Tumor Patients

Influence of recombinant growth hormone on protein metabolism in chronic abdominal infection

The Changes of Serum Cortisol, Pro-B-type Natriuretic Peptide and Interleukin-6 in Critically Ill Children with Stress

Relation of Nutritional Status and Plasma Ghrelin Level of Patients in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.